{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:14:05Z","timestamp":1793654045525,"version":"4.5.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ejmech.2017.04.023","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T11:18:13Z","timestamp":1492168693000},"page":"213-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Synthesis and mechanistic evaluation of novel N \u2019-benzylidene-carbohydrazide-1 H -pyrazolo[3,4 -b ]pyridine derivatives as non-anionic antiplatelet agents"],"prefix":"10.1016","volume":"135","author":[{"given":"Andr\u00e9 L.","family":"Louren\u00e7o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel R.S.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-1445","authenticated-orcid":false,"given":"Max S.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana F.R.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facio M.","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.F.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela M.F.","family":"Muri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.T.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Craik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza R.S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pl\u00ednio C.","family":"Sathler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejmech.2017.04.023_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrcardio.2014.26","article-title":"Epidemiological studies of CHD and the evolution of preventive cardiology","volume":"11","author":"Wong","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib2","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/01.cir.0000441139.02102.80","article-title":"On behalf of the American heart association statistics committee and stroke statistics subcommittee. Heart disease and stroke Statistics\u20132014 update: a report from the American heart association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejmech.2017.04.023_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.hlc.2013.03.001","article-title":"Pathophysiology of atherosclerosis plaque progression","volume":"22","author":"Sakakura","year":"2013","journal-title":"Heart Lung Circ."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/ATVBAHA.112.300210","article-title":"Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and Thrombus Formation","volume":"34","author":"M\u00fcnzer","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11886-012-0280-z","article-title":"Platelet function and inhibition in ischemic heart disease","volume":"14","author":"Nusca","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejmech.2017.04.023_bib6","series-title":"Antiplatelet Drugs: Antithrombotic Therapy and Prevention of Thrombosis","first-page":"e89S","volume":"vol. 141","author":"Eikelboom","year":"2012"},{"key":"10.1016\/j.ejmech.2017.04.023_bib7","first-page":"327","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Cardiovasc Res."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.thromres.2011.11.002","article-title":"Blood platelet biochemistry","volume":"129","author":"Broos","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/09537104.2013.867427","article-title":"Ticagrelor as an alternative in clopidogrel-associated neutropenia","volume":"26","author":"Shah","year":"2015","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/S0100-40422010000100030","article-title":"Metab\u00f3litos Secund\u00e1rios de Origem Vegetal: Uma Fonte Potential de F\u00e1rmacos Antitromb\u00f3ticos","volume":"33","author":"de Almeida Chaves","year":"2010","journal-title":"Quim Nova"},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-013-1035-4","article-title":"Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 phase III studies","volume":"38","author":"Angiolillo","year":"2014","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"key":"10.1016\/j.ejmech.2017.04.023_bib12","first-page":"233","article-title":"Prevalence of aspirin resistance and clinical characteristics in patients with cerebral infarction","volume":"3","author":"Choi","year":"2013","journal-title":"Korean Soc. Biomed. Lab. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib13","first-page":"527","article-title":"Aspirin, platelet P2Y12 receptor inhibitors, and other oral antiplatelets: comparative pharmacology and role in elective PCI","volume":"2","author":"Kunadian","year":"2013","journal-title":"Interv. Cardiol. Clin."},{"issue":"7","key":"10.1016\/j.ejmech.2017.04.023_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5551\/jat.3293","article-title":"Antiplatelet activity and structure-activity relationship study of pyrazolopyridine derivatives as potential series for treating thrombotic diseases","volume":"17","author":"Geraldo","year":"2010","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib15","first-page":"14","article-title":"Synthesis and biological activity of new potential antimalarial: 1H-pyrazolo [3, 4-B] pyridine derivatives","volume":"139","author":"Dias","year":"1999","journal-title":"Boll. Chim. Farm."},{"issue":"5","key":"10.1016\/j.ejmech.2017.04.023_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1021\/ml400066a","article-title":"The 2\u2032-trifluoromethyl analogue of indomethacin is a potent and selective COX-2 inhibitor","volume":"4","author":"Blobaum","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2017.04.023_bib17","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1073\/pnas.0913377107","article-title":"Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition","volume":"107","author":"Limongelli","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.ejmech.2017.04.023_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1054\/plef.2001.0276","article-title":"Do human platelets express COX-2?","volume":"64","author":"Reiter","year":"2001","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib19","first-page":"527","article-title":"Arachidonic acid pathway: a molecular target in human testicular cancer (review)","volume":"2","author":"Matsuyama","year":"2009","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.ejmech.2017.04.023_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1089\/ars.2011.4324","article-title":"Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities","volume":"17","author":"Ferroni","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejmech.2017.04.023_bib21","series-title":"Thrombosis. In Essential Cardiology","first-page":"67","author":"Bacchus","year":"2013"},{"key":"10.1016\/j.ejmech.2017.04.023_bib22","series-title":"Current Cardiovascular Therapy","first-page":"1","article-title":"Antiplatelet agents: current and novel. In antiplatelet and anticoagulation therapy","author":"Heptinstall","year":"2013"},{"key":"10.1016\/j.ejmech.2017.04.023_bib23","series-title":"Platelet Membrane Glycoproteins","author":"George","year":"2013"},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejogrb.2013.06.008","article-title":"Dr Robert proust: a Gynaecologist's contribution to world literature","volume":"170","author":"de Costa","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/14756366.2013.817403","article-title":"Human thromboxane synthase: comparative modeling and docking evaluation with the competitive inhibitors dazoxiben and ozagrel","volume":"24","author":"Sathler","year":"2014","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"issue":"33","key":"10.1016\/j.ejmech.2017.04.023_bib26","doi-asserted-by":"crossref","first-page":"19970","DOI":"10.1074\/jbc.271.33.19970","article-title":"Identification of thromboxane A2 synthase active site residues by molecular modeling-guided site-directed mutagenesis","volume":"271","author":"Wang","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2017.04.023_bib27","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/bi301400t","article-title":"Probing ligand binding to thromboxane synthase","volume":"52","author":"Chao","year":"2013","journal-title":"Biochem. (Mosc.)"},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10822-005-3692-7","article-title":"Molecular design of two sterol 14alpha-demethylase homology models and their interactions with the azole antifungals ketoconazole and bifonazole","volume":"19","author":"Rupp","year":"2005","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"18","key":"10.1016\/j.ejmech.2017.04.023_bib29","doi-asserted-by":"crossref","first-page":"14737","DOI":"10.1074\/jbc.M009177200","article-title":"Substrate binding is the rate-limiting step in thromboxane synthase catalysis","volume":"276","author":"Wang","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2017.04.023_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00394-012-0361-1","article-title":"Antiplatelet effect of new lipophilic hydroxytyrosol alkyl ether derivatives in human blood","volume":"52","author":"Reyes","year":"2013","journal-title":"Eur. J. Nutr."},{"issue":"8","key":"10.1016\/j.ejmech.2017.04.023_bib31","doi-asserted-by":"crossref","DOI":"10.5688\/aj7308143","article-title":"Receptor-grounded approach to teaching nonsteroidal antiinflammatory drug chemistry and structure-activity relationships","volume":"73","author":"Roche","year":"2009","journal-title":"Am. J. Pharm. Educ."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj2040847","article-title":"Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes","volume":"204","author":"Carey","year":"1982","journal-title":"Biochem. J."},{"issue":"12","key":"10.1016\/j.ejmech.2017.04.023_bib33","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1046\/j.1432-1033.2002.02963.x","article-title":"Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes","volume":"269","author":"Christiaens","year":"2002","journal-title":"Eur. J. Biochem. FEBS"},{"issue":"8","key":"10.1016\/j.ejmech.2017.04.023_bib34","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.febslet.2011.03.027","article-title":"The binding of 14-3-3\u03b3 to membranes studied by intrinsic fluorescence spectroscopy","volume":"585","author":"Bustad","year":"2011","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2017.04.023_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nano.2008.08.001","article-title":"Interaction of colloidal Gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles","volume":"5","author":"Dobrovolskaia","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.12980\/APJTB.4.2014C1012","article-title":"Theoretical and experimental study on lipophilicity and wound healing activity of ginger compounds","volume":"4","author":"Bakht","year":"2014","journal-title":"Asian pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejmech.2017.04.023_bib37","first-page":"55","article-title":"The hemolytic and physiological activities of mixtures of some phenoxy and organophosphorous herbicides","volume":"8","author":"Kleszczy\u0144ska","year":"2003","journal-title":"Cell Mol. Biol. Lett."},{"issue":"15","key":"10.1016\/j.ejmech.2017.04.023_bib38","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.113.004834","article-title":"Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients on oral anticoagulant: a nationwide cohort study","volume":"129","author":"Lamberts","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejmech.2017.04.023_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1182\/blood-2012-03-415869","article-title":"Crystal structures of protease Nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ejmech.2017.04.023_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.112.276741","article-title":"Oral direct factor Xa inhibitors","volume":"111","author":"Yeh","year":"2012","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.ejmech.2017.04.023_bib41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCRESAHA.112.264903","article-title":"Translational success stories development of direct thrombin inhibitors","volume":"111","author":"Coppens","year":"2012","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2017.04.023_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/2040622313494987","article-title":"Argatroban in heparin-induced thrombocytopenia: rationale for use and place in therapy","volume":"4","author":"Bambrah","year":"2013","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"16","key":"10.1016\/j.ejmech.2017.04.023_bib43","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1039\/c3ra42347f","article-title":"A\u00a0comparative study of the molecular structure, lipophilicity, solubility, acidity, absorption and polar surface area of coumarinic anticoagulants and direct thrombin inhibitors","volume":"4","author":"Remko","year":"2014","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.ejmech.2017.04.023_bib44","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/jm301905a","article-title":"Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective Cyclooxygenase-1 (COX-1) inhibitors","volume":"56","author":"Vitale","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2017.04.023_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10822-011-9423-3","article-title":"Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor","volume":"25","author":"Deflorian","year":"2011","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"issue":"13","key":"10.1016\/j.ejmech.2017.04.023_bib46","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.110.004424","article-title":"Dabigatran etexilate a new oral thrombin inhibitor","volume":"123","author":"Hankey","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-9560-12-3","article-title":"New oral anticoagulants: are coagulation units still required?","volume":"12","author":"Altman","year":"2014","journal-title":"Thromb. J."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2017.04.023_bib49","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.3390\/toxins2082055","article-title":"Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity","volume":"2","author":"Hagos","year":"2010","journal-title":"Toxins"},{"issue":"7","key":"10.1016\/j.ejmech.2017.04.023_bib50","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4\u2013mediated Transport Evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2017.04.023_bib51","first-page":"15","article-title":"Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part II: potential causes and laboratory tests","volume":"66","author":"Vad\u00e1sz","year":"2013","journal-title":"Ideggy\u00f3gy. Szle."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"Floyd","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.ejmech.2017.04.023_bib53","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/jm201528b","article-title":"Cyclooxygenase-1-Selective inhibitors based on the (E)-2\u2032-Des-Methyl-Sulindac sulfide scaffold","volume":"55","author":"Liedtke","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/187231211796904964","article-title":"Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4","volume":"5","author":"Li","year":"2011","journal-title":"Drug Metab. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2017.04.023_bib55","first-page":"567","article-title":"Pharmacokinetics of ketamine and xylazine in young and old sprague\u2013dawley rats","volume":"52","author":"Veilleux-Lemieux","year":"2013","journal-title":"J.\u00a0Am. Assoc. Lab. Anim. Sci. JAALAS"},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib56","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/toxsci\/kfs127","article-title":"Relationship of metabolism and cell proliferation to the mode of action of fluensulfone-induced mouse lung tumors: analysis of their human relevance using the IPCS framework","volume":"128","author":"Strupp","year":"2012","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2478\/v10102-012-0002-9","article-title":"Damage of testicular cell macromolecules and reproductive capacity of male rats following Co-Administration of ethambutol, rifampicin, isoniazid and pyrazinamide","volume":"5","author":"Shayakhmetova","year":"2012","journal-title":"Interdiscip. Toxicol."},{"issue":"10","key":"10.1016\/j.ejmech.2017.04.023_bib58","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00204-011-0659-4","article-title":"Genotoxicity and carcinogenicity studies of antihistamines","volume":"85","author":"Brambilla","year":"2011","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11883-011-0216-x","article-title":"Novel antiplatelet therapies","volume":"14","author":"Kim","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"issue":"9","key":"10.1016\/j.ejmech.2017.04.023_bib60","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0968-0896(03)00055-5","article-title":"Antiplatelet properties of novel N-Substituted-Phenyl-1,2,3-Triazole-4-Acylhydrazone derivatives","volume":"11","author":"Cunha","year":"2003","journal-title":"Bioorg. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2017.04.023_bib61","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2004.12.002","article-title":"Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen cladonia ibitipocae","volume":"35","author":"Martinichen-Herrero","year":"2005","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.ejmech.2017.04.023_bib62","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmc.2009.03.053","article-title":"Synthesis, antiplatelet and in silico evaluations of novel N-Substituted-Phenylamino-5-Methyl-1H-1,2,3-Triazole-4-Carbohydrazides","volume":"17","author":"Jord\u00e3o","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2017.04.023_bib63","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.thromres.2014.05.009","article-title":"In\u00a0vitro and in\u00a0vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-Acylhydrazone derivatives and development of nanosystems: determination of novel NAH derivatives antiplatelet and nanotechnological approach","volume":"134","author":"Sathler","year":"2014","journal-title":"Thromb. Res."},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2017.04.023_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0009-3084(93)90070-J","article-title":"Toxicity screening of liposomes","volume":"64","author":"Parnham","year":"1993","journal-title":"Chem. Phys. Lipids"},{"issue":"7","key":"10.1016\/j.ejmech.2017.04.023_bib65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-Ethyl-2-Oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in\u00a0vitro cytotoxicity and hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejmech.2017.04.023_bib66","series-title":"Practice for Assessment of Hemolytic Properties of Materials","author":"F04 Committee","year":"2013"},{"issue":"7","key":"10.1016\/j.ejmech.2017.04.023_bib67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0142-9612(02)00445-3","article-title":"In\u00a0vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis","volume":"24","author":"Fischer","year":"2003","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.ejmech.2017.04.023_bib68","doi-asserted-by":"crossref","first-page":"8196","DOI":"10.1016\/j.bmc.2008.07.035","article-title":"Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure\u2013activity relationship studies of 1H-pyrazolo[3,4-B]pyridine and thieno[2,3-B]pyridine derivatives","volume":"16","author":"Leal","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2017.04.023_bib69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/17460441.2010.484460","article-title":"Virtual screening with AutoDock: theory and Practice","volume":"5","author":"Cosconati","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.ejmech.2017.04.023_bib70","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00284-010-9763-6","article-title":"Identification of nor-\u03b2-Lapachone Derivatives as Potential Antibacterial Compounds against Enterococcus Faecalis Clinical Strain","volume":"62","author":"Louren\u00e7o","year":"2011","journal-title":"Curr. Microbiol."},{"issue":"1","key":"10.1016\/j.ejmech.2017.04.023_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/cmb.2014.41001","article-title":"Application of hartree-fock method for modeling of bioactive molecules using SAR and QSPR","volume":"4","author":"Santos","year":"2014","journal-title":"Comput. Mol. Biosci."},{"issue":"16","key":"10.1016\/j.ejmech.2017.04.023_bib72","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2017.04.023_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"issue":"16","key":"10.1016\/j.ejmech.2017.04.023_bib74","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J.\u00a0Comput. Chem."},{"issue":"Pt 8","key":"10.1016\/j.ejmech.2017.04.023_bib75","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Sch\u00fcttelkopf","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"issue":"W1","key":"10.1016\/j.ejmech.2017.04.023_bib76","doi-asserted-by":"crossref","first-page":"W200","DOI":"10.1093\/nar\/gkv353","article-title":"FAF-Drugs3: a web server for compound property calculation and chemical library design","volume":"43","author":"Lagorce","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417302805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417302805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T13:58:32Z","timestamp":1535896712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417302805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":76,"alternative-id":["S0223523417302805"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.023","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and mechanistic evaluation of novel N\u2019-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}